Get the Stockscreener App
48.75
1.06%
0.51
After Hours:
48.30
-0.45
-0.92%
Revolution Medicines Inc stock is traded at $48.75, with a volume of 1.46M.
It is up +1.06% in the last 24 hours and up +4.73% over the past month.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.
See More
Previous Close:
$48.24
Open:
$48.24
24h Volume:
1.46M
Relative Volume:
0.77
Market Cap:
$9.11B
Revenue:
$29.52M
Net Income/Loss:
$-567.06M
P/E Ratio:
-13.32
EPS:
-3.66
Net Cash Flow:
$-551.11M
1W Performance:
+4.66%
1M Performance:
+4.73%
6M Performance:
+36.48%
1Y Performance:
-3.43%
1-Day Range:
$48.00
$49.00
1-Week Range:
$45.80
$49.50
52-Week Range:
$29.17
$62.40
Revolution Medicines Inc Stock (RVMD) Company Profile
Name
Revolution Medicines Inc
Sector
Industry
Phone
415-766-3638
Address
700 SAGINAW DR, REDWOOD CITY, CA
Compare RVMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RVMD
Revolution Medicines Inc
|
48.75 | 9.02B | 29.52M | -567.06M | -551.11M | -3.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Revolution Medicines Inc Stock (RVMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-12-25 | Resumed | Raymond James | Strong Buy |
| Sep-05-25 | Initiated | Truist | Buy |
| Aug-19-25 | Initiated | Piper Sandler | Overweight |
| Aug-15-25 | Initiated | Wells Fargo | Overweight |
| Jul-15-25 | Initiated | Goldman | Buy |
| Jul-16-24 | Reiterated | Needham | Buy |
| Jul-12-24 | Initiated | Barclays | Overweight |
| Jul-08-24 | Initiated | Jefferies | Buy |
| Apr-12-24 | Reiterated | Needham | Buy |
| Apr-10-24 | Upgrade | Raymond James | Outperform → Strong Buy |
| Mar-11-24 | Initiated | Piper Sandler | Overweight |
| Jan-05-24 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-04-24 | Initiated | Wedbush | Outperform |
| Nov-16-23 | Initiated | Raymond James | Outperform |
| Feb-28-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-14-22 | Initiated | Needham | Buy |
| Oct-21-22 | Initiated | Oppenheimer | Outperform |
| May-20-22 | Initiated | BofA Securities | Neutral |
| Mar-01-22 | Upgrade | Stifel | Hold → Buy |
| Sep-23-21 | Initiated | Stifel | Hold |
| Aug-12-21 | Downgrade | Goldman | Buy → Neutral |
| May-18-21 | Initiated | Goldman | Buy |
| May-21-20 | Initiated | H.C. Wainwright | Buy |
| Mar-09-20 | Initiated | Cowen | Outperform |
| Mar-09-20 | Initiated | Guggenheim | Buy |
| Mar-09-20 | Initiated | JP Morgan | Neutral |
View All
Revolution Medicines Inc Stock (RVMD) Latest News
Using data filters to optimize entry into Revolution Medicines Inc. Equity WarrantTrade Risk Summary & High Accuracy Trade Alerts - newser.com
What earnings revisions data tells us about Revolution Medicines Inc.2025 Market WrapUp & Weekly High Return Stock Forecasts - newser.com
Is a relief rally coming for Revolution Medicines Inc. holders2025 Technical Patterns & Long-Term Growth Portfolio Plans - newser.com
How analysts rate Revolution Medicines Inc. stock todayMarket Growth Review & Low Risk High Reward Ideas - newser.com
Will Revolution Medicines Inc. outperform the market2025 Technical Patterns & High Yield Stock Recommendations - newser.com
Measuring Revolution Medicines Inc. Equity Warrant’s beta against major indicesWeekly Investment Report & Weekly Stock Performance Updates - newser.com
How sentiment analysis helps forecast Revolution Medicines Inc. Equity Warrant2025 Sector Review & Fast Moving Stock Watchlists - newser.com
Using data models to predict Revolution Medicines Inc. stock movementJuly 2025 Closing Moves & Stepwise Entry/Exit Trade Alerts - newser.com
How high can Revolution Medicines Inc. Equity Warrant stock goPortfolio Return Summary & High Conviction Investment Ideas - newser.com
What recovery options are there for Revolution Medicines Inc.2025 AllTime Highs & Detailed Earnings Play Alerts - newser.com
Can technical indicators confirm Revolution Medicines Inc.’s reversalTrade Exit Summary & AI Powered Buy/Sell Recommendations - newser.com
Why Revolution Medicines Inc. Equity Warrant stock appeals to dividend seekersOptions Play & Long-Term Capital Growth Ideas - newser.com
Should you wait for a breakout in Revolution Medicines Inc. Equity WarrantGap Up & Community Shared Stock Ideas - newser.com
How Revolution Medicines Inc. stock performs in interest rate cycles2025 Volume Leaders & Verified Momentum Stock Watchlist - newser.com
Revolution Medicines Inc. Equity Warrant stock volume spike explained2025 Volume Leaders & High Conviction Investment Ideas - newser.com
Revolution Medicines (NASDAQ:RVMD) Earns "Sell (D-)" Rating from Weiss Ratings - MarketBeat
How analysts revise price targets for Revolution Medicines Inc. (42Z) stockJuly 2025 Market Mood & Community Consensus Stock Picks - newser.com
What recovery options are there for Revolution Medicines Inc. Equity WarrantQuarterly Portfolio Summary & Low Volatility Stock Recommendations - newser.com
Revolution Medicines’ SWOT analysis: RAS inhibitor stock poised for growth amid fierce competition - Investing.com
Revolution Medicines’ SWOT analysis: RAS inhibitor stock poised for growth amid fierce competition By Investing.com - Investing.com South Africa
What analysts say about Revolution Medicines Inc stockTrendline Breakouts & Explosive Growth Opportunities - earlytimes.in
Did Leadership Moves Just Shift Revolution Medicines' (RVMD) Investment Narrative Ahead of Key Launches? - Yahoo Finance
Is now a turning point for Revolution Medicines Inc. Equity WarrantJuly 2025 Spike Watch & Low Volatility Stock Recommendations - newser.com
Assessing Revolution Medicines After Recent Cancer Breakthrough and 15% Monthly Rally - Yahoo Finance
Real time breakdown of Revolution Medicines Inc. stock performance2025 Technical Overview & Real-Time Stock Movement Alerts - newser.com
Using fundamentals and technicals on Revolution Medicines Inc. Equity WarrantTrade Signal Summary & Daily Profit Maximizing Tips - newser.com
How hedge fund analytics apply to Revolution Medicines Inc. stockQuarterly Earnings Report & Risk Managed Investment Entry Signals - newser.com
Short interest data insights for Revolution Medicines Inc.Weekly Investment Summary & High Accuracy Swing Trade Signals - newser.com
Evaluating Revolution Medicines Inc. with trendline analysisPortfolio Return Report & Stock Portfolio Risk Management - newser.com
Multi factor analysis applied to Revolution Medicines Inc. Equity WarrantTreasury Yields & Proven Capital Preservation Tips - newser.com
Will Revolution Medicines Inc. stock go up soon2025 Retail Activity & Weekly High Momentum Picks - newser.com
Will Revolution Medicines Inc. Equity Warrant stock benefit from upcoming earnings reportsBreakout Watch & Risk Controlled Stock Pick Alerts - newser.com
Advanced analytics toolkit walkthrough for Revolution Medicines Inc. Equity WarrantMarket Sentiment Review & Real-Time Stock Price Movement Reports - newser.com
Will Revolution Medicines Inc. Equity Warrant price bounce be sustainable2025 Top Gainers & Reliable Price Breakout Alerts - newser.com
Is Revolution Medicines Inc. stock vulnerable to regulatory risksSwing Trade & Reliable Volume Spike Trade Alerts - newser.com
Long term hold vs stop loss in Revolution Medicines Inc. Equity WarrantMarket Risk Analysis & Growth Oriented Trade Recommendations - newser.com
Published on: 2025-10-05 02:52:08 - newser.com
Will Revolution Medicines Inc. Equity Warrant outperform the marketEarnings Beat & Weekly High Conviction Trade Ideas - newser.com
Revolution Medicines, Inc. (NASDAQ:RVMD) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Sentiment analysis tools applied to Revolution Medicines Inc.Market Trend Summary & Verified Entry Point Detection - newser.com
Revolution Medicines Inc Stock (RVMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):